NexBio's DAS181 (Fludase) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis - Drugs.com MedNews
Links shared publicly online about this topic.
- 32total visits
NexBio's DAS181 (Fludase) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis - Drugs.com MedNews
NexBio, Inc. announced publication of Treatment of Parainfluenza 3 Infection with DAS181 in a Patient after Allogeneic Stem Cell Transplantation in the Journal
View full resource at drugs.com
Tags: Infection, Sore Throat, Drug, Stem Cell, Transplantation
Most Recently Shared on August 31, 2011 at 2:10 pm By:
NexBio's DAS181 (Fludase) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threaten... http://t.co/WzWcE35 #drug
NexBio's DAS181 (Fludase®*) Improves Symptoms In Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
medicalnewstoday.com — “NexBio, Inc. announced publication of Treatment of Parainfluenza 3 Infection with DAS181 in a Patient after Allogeneic Stem Cell Transplantation in the Journal Clinical Infectious Diseases. The” View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2011 at 10:05 am By:
NexBio's DAS181 (Fludase®*) Improves Symptoms In Four Severely Immunocompromised Patients With Life-Threatening Pa... http://mnt.to/3Zmb
Advertisement
